DMCC Speciality Chemicals Limited AI Stock Analysis
Want to see IN:DMCC full AI Analyst Report?
DMCC Speciality Chemicals Limited (DMCC) AI Stock Analysis
DMCC Speciality Chemicals Limited
(NSE:DMCC)
Overall score is driven primarily by mixed financial quality: a manageable balance sheet and FY2026 revenue/profit recovery are offset by a sharp deterioration in operating/free cash flow. Technicals are weak with the stock trading below key moving averages and negative momentum, while valuation is reasonable (P/E ~15.9) but only modestly supported by the low dividend yield (~1%).
DMCC Speciality Chemicals Limited (DMCC) vs. iShares MSCI India ETF (INDA)
- Market Cap
- INR 6.11B
- Dividend Yield
- 1.01%
- Average Volume (3M)
- 9,000
- Price to Earnings (P/E)
- 16.2
- Beta (1Y)
- 0.56
- Revenue Growth
- 72.14%
- EPS Growth
- 34.49%
- Country
- India
- Employees
- 450
- Sector
- General
- Sector Strength
- 55
- Industry
- Chemicals
DMCC Speciality Chemicals Limited Business Overview & Revenue Model
Company Description
DMCC Speciality Chemicals Limited, alongside its affiliated entities, operates as a manufacturer and global supplier of both specialty and commodity chemicals. Its distribution network spans both domestic Indian markets and international territories....
How the Company Makes Money
null
DMCC Speciality Chemicals Limited Financial Statement Overview
Summary
Balance sheet strength and improving leverage (D/E ~0.35) support stability, and FY2026 revenue rebounded (~17%) with positive profitability. However, cash flow quality is a major weakness: FY2026 operating cash flow and free cash flow turned negative, and the multi-year FCF pattern is inconsistent. Margins are also compressed versus earlier peak years, keeping overall financial strength only moderate.
Income Statement
62PositiveBalance Sheet
68PositiveCash Flow
34Negative| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 8.54B | 5.82B | 4.31B | 3.26B | 3.85B | 3.25B |
| Gross Profit | 1.08B | 935.49M | 1.33B | 1.14B | 1.37B | 1.28B |
| EBITDA | 783.02M | 643.27M | 570.16M | 366.94M | 387.81M | 467.11M |
| Net Income | 374.55M | 273.29M | 215.28M | 115.89M | 69.31M | 213.40M |
Balance Sheet | ||||||
| Total Assets | 4.95B | 4.46B | 3.80B | 3.77B | 4.01B | 3.84B |
| Cash, Cash Equivalents and Short-Term Investments | 49.02M | 44.55M | 51.52M | 70.63M | 33.50M | 29.59M |
| Total Debt | 1.08B | 865.32M | 470.70M | 877.11M | 1.01B | 933.99M |
| Total Liabilities | 2.30B | 1.97B | 1.53B | 1.68B | 2.03B | 1.90B |
| Stockholders Equity | 2.65B | 2.48B | 2.28B | 2.10B | 1.98B | 1.94B |
Cash Flow | ||||||
| Free Cash Flow | 0 | -330.45M | 310.28M | 194.33M | 79.75M | -480.71M |
| Operating Cash Flow | 0 | -270.57M | 380.41M | 383.74M | 298.81M | 506.56M |
| Investing Cash Flow | 0 | -69.76M | -66.82M | -100.42M | -205.59M | -984.14M |
| Financing Cash Flow | 0 | 318.06M | -297.83M | -271.01M | -99.94M | 461.07M |
DMCC Speciality Chemicals Limited Technical Analysis
Price Trends
Market Momentum
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IN:DMCC, the sentiment is Negative. The current price of 244.75 is below the 20-day moving average (MA) of 267.06, below the 50-day MA of 290.28, and below the 200-day MA of 263.90, indicating a bearish trend. The MACD of -16.26 indicates Positive momentum. The RSI at 36.13 is Neutral, neither overbought nor oversold. The STOCH value of 56.76 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for IN:DMCC.
DMCC Speciality Chemicals Limited Peers Comparison
Overall Rating
IN:INDOAMIN76Outperform
IN:DEEPAKNTR65Neutral
IN:VALIANTORG63Neutral
IN:PRIMO59Neutral
IN:DMCC53Neutral
IN:UNIENTER41.4Neutral
Financial Indicators
| Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
| 76Outperform | INR 8.20B | 10.15 | ― | 0.44% | 13.23% | 22.22% | |
| 65Neutral | INR 217.36B | 20.48 | ― | 0.47% | 25.13% | 99.89% | |
| 63Neutral | INR 9.70B | 14.74 | ― | ― | 21.32% | 175.87% | |
| 59Neutral | INR 5.12B | 32.23 | ― | ― | -2.70% | -15.41% | |
| Sector * | 55Neutral | $6.65B | 3.83 | -15.92% | 6.20% | 10.91% | 7.18% |
| 53Neutral | INR 6.10B | 16.25 | ― | 1.01% | 72.14% | 34.49% | |
| 41Neutral | INR 6.73B | 34.90 | ― | 3.60% | -68.82% | 1.74% |
* General Sector Average
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| IN:DMCC | DMCC Speciality Chemicals Limited | 244.75 | -27.31 | -10.04% | |
| IN:DEEPAKNTR | Deepak Nitrite Limited | 1593.65 | -102.70 | -6.05% | |
| IN:INDOAMIN | Indo Amines Limited | 112.95 | -16.43 | -12.70% | |
| IN:PRIMO | Primo Chemicals Limited | 21.13 | -0.94 | -4.26% | |
| IN:UNIENTER | Uniphos Enterprises Limited | 96.78 | -54.69 | -36.11% | |
| IN:VALIANTORG | Valiant Organics Limited | 345.85 | 63.00 | 22.27% |
DMCC Speciality Chemicals Limited Corporate Events
DMCC Speciality Chemicals Says Trading Surge Is Market-Driven, Affirms SEBI Compliance
The speciality chemicals producer DMCC Speciality Chemicals Limited, listed on NSE and BSE under the symbol DMCC and scrip code 506405, serves industrial markets and operates under India’s SEBI Listing Obligations and Disclosure Requirements regime....
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.
Date of analysis: Oct 31, 2026
